Parabilis Medicines, Inc.
Ownership
Ownership Structure
Who owns Parabilis Medicines, Inc. (PBLS)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 67.3% of the shares are freely tradable; institutional investors hold 58.8%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| ARCH VENTURE CORP | 5.19 | 6,412,780 | +0.0 | 06/30/2026 |
| venBio Partners LLC | 4.26 | 5,266,697 | +0.0 | 06/30/2026 |
| Alphabet Inc | 3.98 | 4,919,498 | +0.0 | 06/30/2026 |
| Nextech Invest, Ltd. | 3.77 | 4,663,176 | +0.0 | 06/30/2026 |
| Regeneron Pharmaceuticals Inc | 3.37 | 4,166,666 | +0.0 | 06/30/2026 |
| General Catalyst Group Management, LLC | 1.30 | 1,600,937 | +0.0 | 06/30/2026 |
| General Atlantic Llc | 1.25 | 1,538,461 | +0.0 | 06/30/2026 |
| Soleus Capital Management, L.P. | 1.19 | 1,465,070 | +0.0 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| HBM Healthcare Investments AG Ord | 0.97 | 1,193,961 | +0.0 | 06/30/2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 0.91 | 1,121,000 | +0.0 | 08/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.